Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1088 blog entries.

November 2024

Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to Transform Health Care by Spearheading the AI Revolution

2024-11-29T14:43:24+00:00

The Mount Sinai Health System, one of New York City’s largest academic medical systems, announced the opening of the Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which is dedicated to enhancing health care delivery through the research, development, and application of innovative artificial intelligence (AI) tools and technologies.

Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to Transform Health Care by Spearheading the AI Revolution2024-11-29T14:43:24+00:00

Aiosyn Launches AiosynQC Pulse for External Digital Slide Quality Assessments, Providing Pathology Labs with Insights for Slide Quality Improvement

2024-11-29T10:04:00+00:00

Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced its external digital slide quality assessments to support laboratories in achieving good-quality histology slides—essential for accurate pathology diagnoses. Leveraging comprehensive, data-driven evaluations through AiosynQC Pulse, this service provides laboratories with insights to pinpoint common artifact issues, such as out-of-focus regions or tissue folds, improve digital slide quality, and comply with stringent quality requirements.

Aiosyn Launches AiosynQC Pulse for External Digital Slide Quality Assessments, Providing Pathology Labs with Insights for Slide Quality Improvement2024-11-29T10:04:00+00:00

Join Owkin’s presentation at DP&AI 2024 in London!

2024-11-28T10:13:56+00:00

Owkin is proud to announce its participation in the 11th Digital Pathology & AI Congress: Europe, scheduled for December 11–12, 2024, at the Hilton London Metropole in London, UK. This esteemed event will convene leading professionals to explore the latest advancements in digital pathology and artificial intelligence.

Join Owkin’s presentation at DP&AI 2024 in London!2024-11-28T10:13:56+00:00

Allen Institute Healthy Human Immune Cell Atlas Scales to Over 16 Million Single Cells

2025-06-26T16:06:10+00:00

Time seems to be an enemy to us all, even the cells that make up our bodies. Immune cells are a mysterious and incredibly important class of cells that protect us from pathogens, but normal aging processes can change their composition and function. These changes may hold the key to why certain diseases like arthritis generally appear with age or why the immune response weakens over time. And perhaps, if we define them, these patterns of change can be disrupted to improve human health in aging.

Allen Institute Healthy Human Immune Cell Atlas Scales to Over 16 Million Single Cells2025-06-26T16:06:10+00:00

Novartis Ireland and Deciphex: Pioneering AI Collaboration to Advance Healthcare Innovation

2024-11-26T09:30:28+00:00

Novartis Ireland were delighted to recently mark its Collaboration Agreement with Deciphex, a Dublin-based digital pathology company, at a specially convened panel discussion on Artificial Intelligence (AI).

Novartis Ireland and Deciphex: Pioneering AI Collaboration to Advance Healthcare Innovation2024-11-26T09:30:28+00:00

Deep Learning Models Predict Mismatch Repair Deficiency From Routine Pathology Slides

2024-11-25T16:29:07+00:00

In a recent study, researchers at Wesleyan University (Connecticut, USA) and Gachon University Gil Hospital (Incheon, Republic of Korea) developed a deep learning framework to predict mismatch repair deficiency (MMR-D) status using digitized pathology slides from patients with endometrial cancer.

Deep Learning Models Predict Mismatch Repair Deficiency From Routine Pathology Slides2024-11-25T16:29:07+00:00

Proscia Wins Fast Company’s Next Big Things in Tech Award

2024-11-22T13:14:42+00:00

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to Fast Company’s fourth annual Next Big Things in Tech list honoring emerging technology that has profound impact for industries—from health and sustainability to robotics and artificial intelligence. Its Concentriq software platform was highlighted in the Health category.

Proscia Wins Fast Company’s Next Big Things in Tech Award2024-11-22T13:14:42+00:00

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

2024-11-22T10:25:32+00:00

PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market.

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System2024-11-22T10:25:32+00:00

Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients

2024-11-21T12:30:39+00:00

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, and diagnostics, and Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, have announced a strategic partnership to streamline MSI testing for patients with colorectal cancer (CRC), the second most deadly cancer worldwide[1].

Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients2024-11-21T12:30:39+00:00

AIVIS Showcases AI-Powered HER2 Quantification Solution at AstraZeneca Korea Symposium

2025-06-03T12:25:44+00:00

On November 21, 2024, a symposium hosted by AstraZeneca Korea was held for pathology specialists from the Korean Society of Pathologists. The symposium, attended by approximately 100 leading pathology experts in Korea, focused on paradigm shifts in breast cancer treatment and provided an opportunity to share the latest insights into the pathology diagnosis and treatment of breast cancer.

AIVIS Showcases AI-Powered HER2 Quantification Solution at AstraZeneca Korea Symposium2025-06-03T12:25:44+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top